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INTRODUCTION
Stress-induced analgesia is suppression of pain sen-
sitivity upon exposure to a stressful stimulus. This 
behavioural phenomenon has been known for over 30 
years in experimental animals (Akil et al. 1976) as well 
as in humans (Carr et al 1981). Over 20 years ago, a 
group headed by Sadowski separated two strains of 
mice, one with high sensitivity (HA) and the other 
with low (LA) sensitivity to stress-induced analgesia 
initiated by swim stressor (SSIA), followed by mea-
surement of analgesia with the tail-flick test (Panocka 
et al. 1986a,b). Following this study, both strains were 
extensively screened for biochemical differences. 
Although these studies identified some phenotypic dif-
ferences (Panocka et al. 1991, Marek et al. 1993, 
Sadowski and Panocka 1993, Sadowski and 
Konarzewski 1999, Kest et al. 1999, Sacharczuk et al. 
2010a) none of them fully explained the differences in 
stress-induced analgesia. 
Just recently, electron microscopy structural analy-
sis (Gajkowska et al. 2011) proposed that increased 
leakage of the blood-brain barrier (BBB) in the HA 
line created the differences between the HA and LA 
lines in response to SSIA. The microvascular structure 
of the LA line is similar to the healthy, control group 
of Swiss-Webster mice, whereas the HA line is charac-
terised by a leaky capillary wall. The BBB ultrastruc-
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tural differences between the HA and LA mice indi-
cate that BBB leakage in the HA mouse could be a 
major reason for the high response to SSIA. It is well 
known that stress elevates peripheral endogenous opi-
oid peptide levels (e.g., beta-endorphins). The SSIA 
phenomenon can be explained as a result of the influx 
of endogenous peripheral opioids into the CNS, which 
induces central analgesia. 
Another example of the functional influx of a 
peripheral peptide into the CNS has been presented 
recently (Kastin and Pan 2010). In the current study, 
we present additional evidence that BBB leakage dif-
ferentiates the HA and LA mouse lines. The permea-
bility of the BBB is highly dependent on the func-
tional integrity of the interendothelial junctional com-
plex, especially tight junctions (Wilhelm et al. 2011). 
The principal transmembrane proteins of the cerebral 
endothelial tight junctions include occludin, claudins 
(mainly claudin-5) and junctional adhesion molecules 
(JAM) (Bauer et al. 2011, Liu et al. 2012). Low expres-
sion levels of these proteins can significantly contrib-
ute to an increase in BBB permeability (Krizbai et al. 
2005). Therefore, we decided to investigate the expres-
sion of claudin-5 and occludin in mouse strains that 
show differential sensitivity to SSIA.
Because leakage of the BBB should influence the 
permeability of various circulating peptides, evalua-
tion of the activity of peripherally applied opioid pep-
tides characterised by limited CNS access was chosen. 
Here, we evaluate differences in the analgesic activity 
of intravenously administered endomorphin I, biphalin 
and AA2016 peptides in HA and LA mouse lines. 
METHODS
The animals were handled according to the guide-
lines of the local ethics committee for experimentation 
on animals. They also conform to the International 
Association for the Study of Pain (Zimmerman 1983).
Animals
Swiss-Webster mice selectively bred towards high 
(HA) and low (LA) analgesia (Panocka et al. 1986b) were 
obtained from the Institute of Genetics and Animal 
Breeding at the Polish Academy of Sciences. Briefly, 
outbred mice were exposed to 3-min of swimming in 
20°C water.Two minutes after completion of the swim, 
latency of the nociceptive reflex on a hot plate (at 56°C) 
was measured. Males and females displaying the longest 
(50–60 s) and the shortest (<10 s) post-swim latencies of 
the hind paw flick or lick response were chosen as pro-
genitors of the HA and the LA line, respectively. A simi-
lar procedure was repeated in each offspring generation, 
and only subjects displaying the longest and the shortest 
post-swim hotplate latencies were mated to maintain the 
HA and the LA line, respectively. Unselected Swiss-
Webster mice were used as the control group (C).
Western blotting
The samples for the western blots of occludin and 
claudin-5 from the brains of HA, LA and control ani-
mals (A) were prepared from one-half of the mouse 
brains (5 specimens from each of the three mouse cell 
lines). The proteins were electrophoresed using stan-
dard denaturing SDS-PAGE procedures and blotted on 
polyvinylidene difluoride (Pall, East Hills, NY, USA) 
or nitrocellulose (GE Healthcare, Waukesha, WI, 
USA) membranes. Blocking of the nonspecific binding 
capacity of the membranes was carried out at room 
temperature for 30 min in TBS-T (Tris-buffered saline 
with 0.1% Tween 20) containing either 5% milk (for 
occludin and β-actin) or 3% bovine serum albumin (for 
claudin-5). The blots were incubated with the follow-
ing primary antibodies (diluted in TBS-T): anti-β-actin 
(Sigma): 1:5 000; anti-claudin-5 (Invitrogen): 1:500 and 
anti-occludin (TransLabs, Lexington, KY, USA): 
1:1 000. After washing, the blots were incubated at 
room temperature with an anti-mouse IgG secondary 
antibody (TransLabs, Lexington, KY, USA) diluted 
1:4 000 in TBS-T for 30 min and then washed again in 
TBS-T. The immunoreaction was visualised using 
Immobilon Western Chemiluminescent HRP Substrate 
(Millipore, Billerica, MA, USA) on X-ray film (Agfa, 
Mortsel, Belgium).
Fig. 1. Stress induced analgesia in HA, LA and C mouse 
lines
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Drugs
Morphine was purchased from Polfa-Warszawa, 
Poland. Endomorphine I, biphalin and the AA2016 
peptide were synthesised in house usingthe “in-solu-
tion” method described previously (Lipkowski et al. 
1982, Lukowiak et al. 2009). All of the substances 
were in the hydrochloride form. On the day of an 
experiment, the tested substances were dissolved in 
0.9% sterile saline and administered intravenously 
(IV). Morphine, endomorphine I and the AA2016 pep-
tide were administered at a dose of 4 mg/kg, whereas 
biphalin was delivered at a dose of 2 mg/kg. 
Antinociception
Antinociception was quantified using a radiant-heat tail 
flick nociception assay (Hau et al. 2002). The baseline 
latency was set at 2–3 seconds with a maximum exposure 
to heat (cut-off time) of 7 seconds to avoid thermal dam-
age to the tail. The degree of antinociception was 
expressed as a percentage of the maximum possible effect 
(% MPE), calculated as % MPE = [(post-treatment latency 
− baseline latency)/(cut-off latency − baseline latency)] × 
100. All of the experimental groups consisted of six mice. 
The drugs were administered intravenously (IV) into the 
tail vein. All of the substances were dissolved in 0.9% 
sterile saline and tested in doses previously established. 
Analgesia was assessed at time points of 5, 15, 30, 60 and 
120 minutes. Naloxone (10 mg/kg IP; 100 mL bolus) was 
administered to confirm opioid receptor affinity of the 
peptides (not presented).
Fluorescence activity of mouse brain extracts
AA2016 (4 mg/kg) was injected intravenously into 
the HA, LA and C mouse lines. After 0.5 h, the ani-
mals were decapitated and the brain was removed. 
Samples were prepared from the mouse brains from 5 
homogenate specimens from each mouse line. The 
homogenates were mixed with 4 volumes of ethanol 
and centrifuged. The fluorescence of the supernatants 
was measured at 400 nm. The differences in the emis-
sion intensities are presented in Results. 
Statistics
The data were analysed either with a one-way 
ANOVA or a two-way RM ANOVA followed by the 
Bonferroni post-hoc test for multiple comparisons. The 
data were presented as the mean ± SEM. Statistically 
significant differences are shown as a value equal to or 
exceeding (*) P<0.1 and (**) P<0.05.
RESULTS
Our experiments showed that swim stress significantly 
differentiates between the lines we examined in terms of 
SSIA magnitude, as assessed with the TF test (Fig. 1). The 
amount of SSIA in the NaCl-injected groups was consid-
erably greater in the HA mice compared to the LA or C 
mice. This result indicates a short-lived, but substantial 
increase in the magnitude of SSIA with an SSIA peak at 
5 min after the swim. The LA line expressed some eleva-
tion in the SSIA magnitude, but this was not statistically 
significant from the control group. Moreover, the effect of 
time was non-significant in the LA line, which indicates 
that the low SSIA values remained relatively stable across 
the measured time points. However, the low SSIA in the 
LA mice was substantially higher than in the C mice.
Fig. 2. Western blot of occludin and claudin-5 from brains of 
HA, LA and C mice lines (A) and densitometric analysis of 
the blots (B). Due to posttranslational modifications (phos-
phorylation on serine, threonine and tyrosine residues) 
occludin presents a series of bands between 62 and 82 kDa 
on the blots (Gonzalez-Mariscal et al.  2003). The bands 
used for quantification have been marked with “→(“. In case 
of claudin-5 only one band of 23 kDa (marked with “→“) 
has been analysed.
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Western blots of occludin and claudin-5 from the brains 
of HA, LA and C animals showed a differential expres-
sion pattern (Fig. 2A). Densitometry analyses of the blots 
(Fig. 2B) showed that both occludin and claudin-5 concen-
trations are lower in the HA lines compared to the LA and 
C lines (Fig. 2B). Expression of both proteins was signifi-
cantly lower in the HA mice compared to the LA.
Morphine given intravenously to the HA, LA and 
control lines resulted in the same level of antinocicep-
tion in all three mouse lines (Fig. 3). In contrast, endo-
morphin I (at a dose of 4 mg/kg, IV) given to the 
control and LA mice did not induce any antinocicep-
tion. However, the same dose induced significant anti-
nociception in the HA mice (Fig. 4). Similar results 
were obtained in the case of intravenous administra-
tion of biphalin. The antinociceptive effect in the HA 
line was very strong and prolonged (Fig. 5). An anti-
nociceptive effect in the LA line was also observed at 
the dose applied but was significantly lower. The anti-
nociceptive effect of AA2016 was also strong in the 
HA line and significantly higher than the observed 
antinociception in the LA and control mice (Fig. 6). 
All antinociceptive effects were reversed by naloxone 
that confirmed opioid receptors involvement. The con-
centrations of AA2013, estimated as fluorescence 
activity of the ethanol extract in the brain homoge-
nates, showed higher values in the HA line compared 
to the LA line and the control animals (Fig. 7).  
DISCUSSION
The BBB is located at the interface of the CNS and 
the periphery. Blood circulation into the BBB regu-
lates the passage of signalling molecules from the 
periphery into the CNS, as well as from the CNS into 
the periphery. Differences in BBB permeability are 
implicated in the pathogenesis of a considerable num-
ber of neurological disorders (Neuwelt 2004, Persidsky 
et al. 2006, Friedman et al. 2009) and also play impor-
tant roles in individual responses to various behav-
ioural and environmental factors (e.g., Banks and 
Kastin 1996, Lossinsky and Shivers 2004, Hawkins 
and Egleton 2008). Our recent analysis indicated that a 
pathological structure of the BBB in the HA mouse 
Fig. 5. Antinociception of biphalin (2 mg/kg) in HA, LA and 
C mice lines (*P<0.05, **P<0.001)
Fig. 6. Antinociception of AA2016 (4 mg/kg) in HA, LA and 
C mice lines (*P<0.05, **P<0.001).
Fig. 3.  Antinociception of morphine (4 mg/kg) in HA, LA and 
C mice. No significance were observed between mice lines.
Fig. 4. Antinociception of endomorphin I (4 mg/kg) in HA, 
LA and C mice lines (*P<0.05, **P<0.001).
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line differentiates the two mouse lines (HA and LA), 
which have different sensitivity to SSIA. We hypoth-
esised that the significantly stronger analgesia observed 
in the HA strain is a result of penetrating endogenous 
opioids from the periphery into the CNS (Gajkowska 
et al. 2010). The observed small levels of SSIA in the 
LA mice indicated that even in this line, stress slightly 
influenced BBB permeability. Further analysis of 
occludin and claudin-5 concentrations showed signifi-
cant decreases in the concentration of both proteins. 
These data provide further evidence for BBB 
impairment of the HA mouse. Additional arguments 
were provided using in vivo studies of peripherally 
applied morphine and opioid peptides. The morphine, 
which has quite well BBB permeability, applied intra-
venously expressed similar high antinociceptive 
effects for all HA, LA and C mouse lines. Endomorphin 
I is a tetrapeptide that is a very potent analgesic after 
central administration (ICV or IT), but its lack of 
effective BBB permeability results in loss of activity 
after systemic (IV) application (Zadina et al. 1997, 
Mallareddy et al. 2012). In our studies, we confirmed 
that intravenous administration of endomorphin I at a 
dose of 4 mg/kg did not express significant antinoci-
ception in the tail-flick test in both the C and LA 
groups. On the contrary, the same dose produced sig-
nificant antinociception effects in the HA mouse line, 
confirming a more effective influx through the BBB. 
Biphalin is a dimeric enkephalin analogue that 
induces antinociception similar to morphine after 
intravenous administration. However, after applica-
tion directly to the CNS, it induced over 100-times 
higher antinociception than morphine (Kosson et 
al. 2008), which indicates the limitation of BBB 
permeability. Therefore, the significantly higher 
antinociception in the HA compared to the LA line 
provides evidence for differences in BBB func-
tional effectiveness. Similar differences have been 
observed during the intravenous administration of 
the fluorescent opioid peptide analogue AA2016 
(Lukowiak at al. 2009). The differences between 
observed antinociception in HA and LA and C lines 
well correlate with fluorescence differences of 
brain extracts. Although the proportion of the anal-
gesic effects between the intravenous administra-
tion of opioid peptides in the HA and LA mouse are 
significant, their levels did not reach the activity 
levels of peptides applied directly to the CNS (IT or 
ICV). These data may suggest that the BBB in the 
HA line is only deviated rather than fully open. 
Higher fluorescence of the HA brain extracts com-
pared to the LA and control lines additionally con-
firms that the BBB is more permeable to opioid 
peptides in the HA line. The provided data support 
our previous hypothesis that BBB leakage is a 
major difference between the two mice lines diver-
gently bred for high and low SSIA. The functional 
differences of the BBB in the HA and LA mouse 
lines are summarised in Figure 8. 
In mice, stress induces the release of endogenous 
peptides into the bloodstream. In the HA mouse, the 
leaky BBB allows the penetration of systemic circu-
lating endogenous opioid peptides into the CNS to 
stimulate antinociception, described as SSIA. Opioid 
peptides given intravenously behave similarly to 
endogenous opioids, effectively penetrating into the 
leaky BBB in the HA line. The permeability of the 
BBB in the LA line is proportional to the peptide 
properties but is generally decreased in comparison 
to the HA line. On the contrary, the BBB permeabil-
ity of morphine is similar in the three mouse lines 
(C, HA and LA).The lack of significant differences 
in non-peptidic (morphine or SN80) BBB permea-
bility was most likely the reason behind the failure 
to obtain conclusive results after years of searching 
for differences between the HA and LA mouse 
lines.  
Fig. 7. Level of AA2016 in whole brain homogenate in HA, 
LA and C mice lines
Blood-brain barrier of LA and HA mouse lines 31 
CONCLUSIONS
Our results indicate that an altered BBB is the 
basis for differences in the stress response between 
the HA and LA mouse lines. Endogenous opioid 
peptides released by stress in the periphery can 
penetrate more easily into the CNS in the HA ani-
mals to induce central analgesia. Similarly, exoge-
nous peptide applied to the periphery (IV) can 
penetrate the BBB and induce central analgesia. In 
contrast, the BBB in the LA line and control mice 
limits the permeability of endogenous and exoge-
nous peptides, resulting in reduced central analge-
sia. The presented results are focused on opioids 
and stress-induced analgesia. However, the HA/LA 
two mouse line model may serve as a general natu-
ral model of pathological impairment of BBB per-
meability in studies of communication between the 
CNS and periphery.
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